CVS Health Corp (CVS) Stock Price Today
Aura AI Summary
Key Stats
- $123.73BMarket Cap
- -Volume
- HealthSector
- $110.6052W High
- $70.0852W Low
- -Typical Hold Time
- $186.08BEnterprise Value
- 2.75%Div Yield
- -Trading Activity
Track CVS Health Corp (CVS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, CVS Health Corp has traded between a low of $70.08 and a high of $110.6, highlighting its annual price range. Buy and sell CVS Health Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Most Recent News
Rep. David J. Taylor shifts stock portfolio from biotech and tech to utilities, semiconductors, and regional banking.
Representative David J. Taylor of Ohio reported six stock trades, selling biotech and tech shares like Amgen and Microsoft, while buying utilities, semiconductors, and regional bank stocks such as American Electric Power, Broadcom, and Fifth Third Ba...

San Diego Starbucks supervisor leads effort to disband union over exclusion and strike impact
A Starbucks shift supervisor in San Diego, Joe Emmenegger, is pushing to disband the union at his store after claiming workers, including supervisors, were excluded from key decisions like the recent open-ended Christmas strike. Emmenegger gathered s...

Investor sells Ares Capital shares after buying the dip earlier this summer
Samuel Smith, an experienced dividend stock analyst, recently sold his position in Ares Capital Corporation after initially buying the dip earlier this summer. He had previously rated the company as a buy, considering it a strong business development...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.